HeartWare Warning Letter Details Inadequate Responses

HeartWare International disclosed a month ago that it had received a warning letter from the FDA. Now more details are out from the FDA over the alleged lack of corrective action procedures and other issues that sparked the FDA warning.

The FDA warning letter came after the agency's January inspection of the company's operations, development and manufacturing facility in Miami Lakes, FL.

Help employers find you! Check out all the jobs and post your resume.